‘Unfortunately, couldn’t see sun’: PM blames clouds for missing solar eclipse

Idukki, Aug 8: Nine more bodies have been recovered from the landslide ravaged Pettimudi near Munnar in Idukki on Saturday. With this the death toll in the tragedy reached 26. Around 40 are feared to be still trapped under the debris or washed away.

The rescue operation by NDRF and Fire and Rescue Services that was stopped by Friday evening due to poor light and bad weather resumed by Saturday morning.

Horrifying scene prevailed in the area as relatives of the missing people screamed around in search of their beloved ones. As it is nearly 48 hours since the incident happened, the chances of recovering missing persons alive from the debris is becoming bleak. Three of the bodies recovered on Saturday could not be identified till evening.

Kerala Revenue Minster E Chandrasekharan, who visited the area on Saturday, said that search operation would be carried out until all the missing are recovered.

It was by around 11.30 pm on Thursday that landslide had hit the Nayamakkad estate of Kannan Devan Hills and Plantations. Settlement clusters of plantation workers where 83 persons were staying were reduced to debris as the huge rocks came bulldozing. Five of the residents were reported to be not in the spot while the mishap occured.

Meanwhile, heavy rains led to floods at many parts of the state. Red alert has been issued at Idukki, Malappuram and Wayanad districts for Sunday also. A total of 11,446 persons of 3,530 families were shifted to relief camps across the state, of which major chunk is at Wayanad.

Chief Minister Pinarayi Vijayan said that water level at most dams is increasing swiftly.

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.